Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Seres Therapeutics (MCRB) over the last 11 years, with Q3 2025 value amounting to $3.1 million.

  • Seres Therapeutics' Prepaid Assets fell 4901.7% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4901.7%. This contributed to the annual value of $5.8 million for FY2024, which is 2777.98% down from last year.
  • Seres Therapeutics' Prepaid Assets amounted to $3.1 million in Q3 2025, which was down 4901.7% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Seres Therapeutics' Prepaid Assets ranged from a high of $15.2 million in Q1 2022 and a low of $2.4 million during Q2 2025
  • Moreover, its 5-year median value for Prepaid Assets was $8.8 million (2021), whereas its average is $8.6 million.
  • Per our database at Business Quant, Seres Therapeutics' Prepaid Assets surged by 13195.92% in 2022 and then crashed by 6233.1% in 2025.
  • Quarter analysis of 5 years shows Seres Therapeutics' Prepaid Assets stood at $12.9 million in 2021, then rose by 3.88% to $13.4 million in 2022, then plummeted by 40.04% to $8.0 million in 2023, then decreased by 27.78% to $5.8 million in 2024, then crashed by 46.46% to $3.1 million in 2025.
  • Its Prepaid Assets stands at $3.1 million for Q3 2025, versus $2.4 million for Q2 2025 and $4.5 million for Q1 2025.